• Alda 1: From Aldehyde Detox to Cardiac Repair

  2026-08-11

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiac stress and repair biology. This article presents an assay-centered framework for interpreting ALDH2 activation across ischemia, pressure overload, and radiation injury models.

• Aurora A, SAM Metabolism, and Trained Immunity

  2026-08-10

  Li et al. identify Aurora kinase A as a regulator of β-glucan-trained immunity through the mTOR–FOXO3–GNMT axis, which preserves endogenous S-adenosylmethionine and active histone methylation. The work connects kinase signaling, metabolic state, chromatin accessibility, and inflammatory memory, while showing that Aurora A inhibition weakens β-glucan-associated tumor suppression in mice.

• Prednisone Workflows for Immunology Research

  2026-08-09

  Prednisone enables controlled studies of lymphocyte suppression, G1 arrest, and apoptosis in primary human immune cells. This practical guide combines dose-and-time assay design with digestion-aware analytical thinking to improve reproducibility and translational interpretation.

• Tetracycline Hydrochloride: Protocols & Use Cases

  2026-08-08

  Build more reliable bacterial growth-inhibition, translation, and skin microbiome workflows with Tetracycline Hydrochloride. This guide pairs practical assay conditions with controls that distinguish bacteriostatic growth arrest from irreversible killing and places the antibiotic alongside a contrasting ROS-driven therapeutic study.

• Sabutoclax: Pan-Bcl-2 Inhibitor Workflow

  2026-08-07

  Sabutoclax is a cell-permeable pan-Bcl-2 inhibitor for dissecting how anti-apoptotic signaling shapes cancer-cell survival. This workflow pairs growth, viability, and death measurements so researchers can distinguish cytostatic effects from true apoptosis induction in cancer cells.

• WM-8014: Precision KAT6A Inhibitor for Advanced Cancer Biolo

  2026-08-07

  WM-8014 stands out as a nanomolar-potency, selective KAT6A inhibitor enabling precise oncogene-induced senescence and cell cycle arrest assays with minimal cytotoxicity. This article guides researchers through optimized protocols, advanced applications, and troubleshooting strategies for leveraging WM-8014 in epigenetic and cancer biology research.

• Arachidonic Acid (SKU C4223): Reliable Solutions for Cell As

  2026-08-06

  This article dissects five real-world challenges in cell-based assay workflows and demonstrates how Arachidonic Acid (SKU C4223) delivers reproducible, mechanism-driven results. Drawing on best practices and new research, it guides biomedical researchers in optimizing eicosanoid pathway modeling, assay compatibility, and vendor selection for reliable data.

• Brefeldin A in Cancer and ER Stress: Protocols & Troubleshoo

  2026-08-06

  Brefeldin A (BFA) stands out for its dual role as an ER stress inducer and apoptosis trigger in cancer research, uniquely enabling mechanistic studies of protein trafficking and vesicle transport. This guide translates recent discoveries and hands-on protocol insights into actionable workflows, helping researchers optimize experiments with APExBIO’s trusted BFA reagent.

• UBR1 and UBR2: Central ER Stress Sensors in Mammalian PQC

  2026-08-05

  The study by Le et al. uncovers UBR1 and UBR2 as key E3 ubiquitin ligases that function as central sensors of endoplasmic reticulum (ER) stress in mammalian protein quality control (PQC) systems. Their findings highlight a novel adaptive mechanism in which stabilization of these N-recognins under ER stress modulates apoptosis sensitivity, offering new insights into ER-associated degradation and its relevance for disease models.

• ORF3a Q57H Variant Dampens Apoptotic Activity in Host Cells

  2026-08-05

  This article examines how the SARS-CoV-2 ORF3a Q57H mutation reduces pro-apoptotic signaling in host cells, likely influencing COVID-19 severity and transmissibility. The findings offer insight into viral adaptation and inform future apoptosis research methodology.

• Prochlorperazine in Translational Oncology: Mechanistic Insi

  2026-08-04

  Explore the dual role of Prochlorperazine as a dopamine D2 receptor antagonist and anticancer agent. This article uniquely examines its mechanistic action in melanoma research and highlights clinical safety insights for advanced laboratory applications.

• Telmisartan in Translational Cardiac Hypertrophy Research

  2026-08-04

  This thought-leadership article explores the evolving landscape of cardiac hypertrophy research, focusing on Telmisartan as a mechanistically validated angiotensin II receptor antagonist. By integrating recent signaling insights, competitive assay considerations, and workflow guidance for translational researchers, this piece clarifies how APExBIO’s Telmisartan (SKU A8531) elevates cardiovascular disease studies and opens new avenues beyond conventional compound selection.

• ac4C-Modified lncRNA Gm26917 Enhances Translation in FGSCs

  2026-08-03

  This study uncovers the mechanistic role of N4-acetylcytidine (ac4C) modification on the lncRNA Gm26917 in promoting translation efficiency in female germline stem cells (FGSCs) by mediating its interaction with ribosomal protein mRNA via EEF1A1. The findings clarify how ac4C-dependent lncRNA-protein spatial networks underpin stem cell maintenance and offer new avenues for fertility and cell fate research.

• LNPs with Adjuvant and Antigen mRNA Enhance Influenza Immuni

  2026-08-03

  This study demonstrates that lipid nanoparticles co-encapsulating both cytokine adjuvant mRNAs and antigen mRNAs significantly enhance immune responses and cross-protection against influenza in mice. The findings highlight an advanced mRNA vaccine strategy that improves systemic and mucosal immunity, with important implications for future vaccine design.

• Transcranial K+-Selective Channelrhodopsin for Seizure Suppr

  2026-08-02

  This study introduces HcKCR1-hs, a highly light-sensitive, K+-selective channelrhodopsin engineered for noninvasive, transcranial optogenetic inhibition of neuronal hyperactivity. The innovation enables robust suppression of epileptic seizures in murine models without the need for invasive procedures, advancing neuromodulatory strategies for epilepsy and related disorders.

7865 records 9/525 page Previous Next First page 上5页 678910 下5页 Last page